ROCKET PHARMACEUTICALS, INC.
RCKT
DELAYED 1 MONTH

9 insider filings · Latest: May 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 21, 2026May 26 11:47 PMGaurav ShahCEO
Sale
55,684$3.09$171.8K1,061,724(D)

View →

May 19, 2026May 21 8:06 PMGaurav ShahCEO
Sale
2,409$3.01$7.3K1,040,918(D)

View →

May 19, 2026May 21 8:06 PMMartin WilsonGeneral Counsel
Sale
662$3.01$2.0K677,977(D)

View →

May 19, 2026May 21 8:06 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Sale
384$3.01$1.2K89,780(D)

View →

May 13, 2026May 14 8:22 PMMartin WilsonGeneral Counsel
Sale
3,361$3.61$12.1K678,639(D)

View →

May 13, 2026May 14 8:19 PMGaurav ShahCEO
Sale
2,728$3.61$9.8K1,043,327(D)

View →

May 13, 2026May 14 8:16 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Sale
855$3.61$3.1K90,164(D)

View →

May 7, 2026May 11 11:48 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Sale
17,650$3.84$67.7K267,510(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Grant/Award
116,562$3.009,091(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Disposition
238,256$62.320(D)

View →

May 21, 2026May 26 11:47 PMGaurav ShahCEO
Option Exercise
76,490$1.690(D)

View →